flecainide has been researched along with thiazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, S; Hashimoto, H; Ishii, M; Nagashima, S; Nakashima, M; Uematsu, T; Umemura, K | 1 |
| Iida, M; Kodama, I; Toyama, J | 1 |
| Carbonara, R; Conte Camerino, D; Costanza, T; Desaphy, JF | 1 |
3 other study(ies) available for flecainide and thiazoles
| Article | Year |
|---|---|
Comparison of electrophysiologic and hemodynamic effects of SD-3212, a new antiarrhythmic drug, and flecainide in a canine myocardial infarction model.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrophysiology; Flecainide; Heart Conduction System; Hemodynamics; Myocardial Infarction; Thiazoles | 1994 |
Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Aprindine; Calcium Channel Blockers; Dose-Response Relationship, Drug; Flecainide; Heart Conduction System; In Vitro Techniques; Membrane Potentials; Quinidine; Rabbits; Sodium Channels; Thiazoles | 1996 |
Preclinical evaluation of marketed sodium channel blockers in a rat model of myotonia discloses promising antimyotonic drugs.
Topics: Animals; Carbamazepine; Disease Models, Animal; Flecainide; HEK293 Cells; Humans; Mexiletine; Muscle, Skeletal; Myotonia Congenita; Orphenadrine; Piperidines; Propafenone; Rats; Rats, Wistar; Riluzole; Sodium Channel Blockers; Thiazoles | 2014 |